Skip to main content

Peer Review reports

From: The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort

Original Submission
18 Mar 2024 Submitted Original manuscript
22 Mar 2024 Author responded Author comments - Shengguang Zhao
4 Apr 2024 Reviewed Reviewer Report
24 Jul 2024 Reviewed Reviewer Report
31 Jul 2024 Author responded Author comments - Shengguang Zhao
Resubmission - Version 2
22 Mar 2024 Submitted Manuscript version 2
Publishing
6 Aug 2024 Editorially accepted
20 Aug 2024 Article published 10.1186/s12885-024-12774-w

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us